Amata Corporation PCL (BKK:AMATA)

CTI BioPharma Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,745	33,063	30,763	24,495	24,150	18,745
Market Cap Growth	-14.64%	7.48%	25.59%	1.43%	28.83%	-12.60%
Enterprise Value	41,827	53,593	49,923	42,458	41,465	36,440
Last Close Price	16.30	27.77	25.08	19.42	18.70	14.27
PE Ratio	6.57	13.32	16.32	10.46	17.22	16.99
Forward PE	6.66	11.78	13.75	14.06	17.34	13.07
PS Ratio	1.21	2.23	3.20	3.70	4.64	4.36
PB Ratio	0.65	1.18	1.20	1.00	1.10	1.00
P/TBV Ratio	1.19	2.18	2.09	2.15	2.30	1.79
P/FCF Ratio	1.74	3.38	3.72	8.84	10.54	17.71
P/OCF Ratio	1.73	3.35	3.57	8.01	10.08	16.49
PEG Ratio	0.57	0.73	0.87	0.87	0.33	0.33
EV/Sales Ratio	2.70	3.61	5.19	6.42	7.97	8.47
EV/EBITDA Ratio	7.60	13.22	16.97	16.49	21.27	21.18
EV/EBIT Ratio	8.28	14.67	19.49	19.01	25.92	26.24
EV/FCF Ratio	3.89	5.48	6.03	15.32	18.10	34.42
Debt / Equity Ratio	0.77	0.66	0.72	0.64	0.74	0.86
Debt / EBITDA Ratio	4.97	4.50	6.22	5.99	8.13	9.22
Debt / FCF Ratio	2.07	1.89	2.25	5.66	7.11	15.19
Asset Turnover	0.24	0.24	0.18	0.14	0.12	0.11
Inventory Turnover	0.72	0.70	0.51	0.43	0.36	0.28
Quick Ratio	0.33	0.37	0.29	0.34	0.51	0.69
Current Ratio	0.99	1.08	1.32	1.30	1.53	2.64
Return on Equity (ROE)	13.60%	12.91%	9.82%	13.63%	9.63%	7.85%
Return on Assets (ROA)	3.94%	3.73%	3.04%	3.00%	2.33%	2.27%
Return on Capital (ROIC)	5.27%	5.03%	3.79%	3.56%	2.73%	2.66%
Return on Capital Employed (ROCE)	8.10%	8.10%	6.10%	5.70%	4.30%	3.80%
Earnings Yield	15.20%	7.51%	6.13%	9.56%	5.81%	5.89%
FCF Yield	57.34%	29.60%	26.89%	11.32%	9.49%	5.65%
Dividend Yield	4.91%	2.88%	2.59%	3.09%	2.14%	2.10%
Payout Ratio	26.24%	30.10%	39.66%	24.56%	24.60%	33.84%
Buyback Yield / Dilution	0.35%	-	-	-	-6.11%	-1.57%
Total Shareholder Return	5.35%	2.88%	2.59%	3.09%	-3.97%	0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.